Wolfram Doehner
Overview
Explore the profile of Wolfram Doehner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
311
Citations
10513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
von Haehling S, Doehner W, Evertz R, Garfias-Veitl T, Derad C, Diek M, et al.
Eur Heart J
. 2024 Aug;
45(37):3789-3800.
PMID: 39185895
Background And Aims: Evidence is lacking that correcting iron deficiency (ID) has clinically important benefits for patients with heart failure with preserved ejection fraction (HFpEF). Methods: FAIR-HFpEF was a multicentre,...
12.
Ntaios G, Baumgartner H, Doehner W, Donal E, Edvardsen T, Healey J, et al.
Eur Heart J
. 2024 Apr;
45(19):1701-1715.
PMID: 38685132
One in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS), defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The overall cardiovascular risk of...
13.
Frohlich A, Porthun J, Talha K, Lena A, Hadzibegovic S, Wilkenshoff U, et al.
Clin Res Cardiol
. 2024 Apr;
PMID: 38587563
Background: Growth hormone (GH) resistance is characterized by high GH levels but low levels of insulin-like growth factor-I (IGF-I) and growth hormone binding protein (GHBP) and, for patients with chronic...
14.
Adamou A, Chlorogiannis D, Kyriakoulis I, Stamatiou I, Koukousaki D, Kardoutsos I, et al.
Intern Emerg Med
. 2024 Feb;
19(2):565-573.
PMID: 38353880
Sodium-glucose cotransporter-2 (SGLT2) inhibitors improve outcomes in patients with heart failure, with or without diabetes. We sought to assess whether there is an interaction of these effects with body mass...
15.
Sandek A, Gertler C, Valentova M, Jauert N, Wallbach M, Doehner W, et al.
J Clin Med
. 2024 Feb;
13(3).
PMID: 38337428
: Cardiac cachexia (CC) in chronic heart failure with reduced ejection fraction (HFrEF) is characterized by catabolism and inflammation predicting poor prognosis. Levels of responsible transcription factors like signal transducer...
16.
Doehner W, Akyea R, Ntaios G
Eur Heart J
. 2024 Jan;
45(16):1484-1485.
PMID: 38240033
No abstract available.
17.
Coats A, Butler J, Tsutsui H, Doehner W, Filippatos G, Ferreira J, et al.
J Cachexia Sarcopenia Muscle
. 2023 Dec;
15(1):412-424.
PMID: 38158636
Background: Frailty is a severe, common co-morbidity associated with heart failure (HF) with preserved ejection fraction (HFpEF). The impact of frailty on HFpEF outcomes may affect treatment choices in HFpEF....
18.
Doehner W, Bohm M, Boriani G, Christersson C, Coats A, Haeusler K, et al.
Eur J Heart Fail
. 2023 Oct;
25(12):2107-2129.
PMID: 37905380
Heart failure (HF) is a major disease in our society that often presents with multiple comorbidities with mutual interaction and aggravation. The comorbidity of HF and stroke is a high...
19.
Akyea R, Ntaios G, Doehner W
J Cachexia Sarcopenia Muscle
. 2023 Oct;
14(6):2653-2662.
PMID: 37806948
Background: The association between metabolic syndrome and increased cardiovascular disease (CVD) risk is well-established. However, in patients with incident CVD, the relationship between obesity, metabolic health, and subsequent CVD and...
20.
Doehner W, Celutkiene J, Yilmaz M, Coats A
QJM
. 2023 Jul;
116(11):897-902.
PMID: 37481714
In heart failure (HF) strong haemodynamic and neuronal signalling feedback interactions between the heart and the central nervous system (CNS) exist that are able to mutually provoke acute or chronic...